Medshine Discovery Inc. and Jiangsu Chia Tai Tianqing Pharmaceutical Group Co. Ltd. have disclosed bicyclic substituted aromatic carboxylic acid compounds acting as complement factor B (CFB) inhibitors reported to be useful for the treatment of Parkinson's disease.